Gene-Eden-VIR is a natural
remedy that helps the immune system kill the latent Human
Papillomavirus (HPV). The following information was published by the Centers for Disease Control and Prevention (CDC)
on its website. In brackets and italic letters, you can find
our comments on the CDC information. Also note our yellow highlights.
Most people with HPV do not develop symptoms or health problems. But sometimes, certain types of HPV can cause genital warts in men and women. Other HPV types can cause cervical cancer and other less common cancers, such as cancers of the vulva, vagina, anus, and penis. The types of HPV that can cause genital warts are not the same as the types that can cause cancer.
[Click on Dormant HPV and Cervical Cancer to learn how a latent human papillomavirus can cause cancer and other diseases.]
HPV types are often referred to as "low-risk" (wart-causing) or "high-risk" (cancer-causing), based on whether they put a person at risk for cancer. In 90% of cases, the body's immune system clears the HPV infection naturally within two years. This is true of both high-risk and low-risk types.
[Note: In 10% of the cases the immune system is too weak to clear the latent HPV! In these cases, Gene-Eden-VIR can help the immune system kill the dormant (latent) HPV virus.]
Genital warts usually appear as small bumps or groups of bumps, usually in the genital area. They can be raised or flat, single or multiple, small or large, and sometimes cauliflower shaped. They can appear on the vulva, in or around the vagina or anus, on the cervix, and on the penis, scrotum, groin, or thigh. Warts may appear within weeks or months after sexual contact with an infected person. Or, they may not appear at all. If left untreated, genital warts may go away, remain unchanged, or increase in size or number. They will not turn into cancer.
Cervical cancer does not have symptoms until it is quite advanced. For this reason, it is important for women to get screened regularly for cervical cancer.
[Screening is very important. However, if you are infected with the HPV virus, you can win the battle against it by helping the immune system kill the dormant (latent) human papillomaviruses, the sleeping soldiers of the HPV virus. Without new soldiers you will win and the HPV virus will lose.]
Do you want to help your immune system kill the dormant (latent) HPV virus? Take Gene-Eden-VIR, the antiviral natural remedy.
The development of Gene-Eden-VIR was inspired by Dr. Hanan Polansky's research of dormant (latent) viruses.
Before you buy Gene-Eden-VIR, you might want to read about Dr. Hanan Polansky and his highly acclaimed scientific achievements. Just enter his name in Google, and follow the links.
Other less common HPV-related cancers, such as
cancers of the vulva, vagina, anus and penis, also may not have signs
or symptoms until they are advanced.
[Do you want a better understanding on how the Human Papillomavirus (HPV) can cause cancer? Click on dormant (latent) viruses and cancer].
How common are HPV and related diseases?
HPV infection. Approximately 20 million Americans are currently infected with HPV, and another 6.2 million people become newly infected each year. At least 50% of sexually active men and women acquire genital HPV infection at some point in their lives.
Genital warts. About 1% of sexually active adults in the U.S. have genital warts at any one time.
Cervical cancer. The American Cancer Society estimates that in 2008, 11,070 women will be diagnosed with cervical cancer in the U.S.
Other HPV-related cancers are much less common than cervical cancer. The American Cancer Society estimates that in 2008, there will be:
Certain populations may be at higher risk for HPV-related cancers, such as gay and bisexual men, and individuals with weak immune systems (including those who have HIV/AIDS).
RRP is very rare. It is estimated that less than 2,000 children get RRP every year.
How can people prevent HPV?
There is currently no vaccine licensed to prevent HPV-related
diseases in men. Studies are now being done to find out if the vaccine
is also safe in men, and if it can protect them against HPV and
related conditions. The FDA will consider licensing the vaccine for
boys and men if there is proof that it is safe and effective for them.
There is also no approved screening test to find early signs of
penile or anal cancer. Some experts recommend yearly
anal Pap tests for gay and bisexual men and for HIV-positive persons
because anal cancer is more common in these populations. Scientists
are still studying how best to screen for penile and anal cancers in
those who may be at highest risk for those diseases.
The HPV test on the market is only used as part of cervical cancer
screening. There is no general test for men or women to check one's
overall "HPV status. HPV usually goes away on its own, without
causing health problems. So an HPV infection that is found today will
most likely not be there a year or two from now. For this reason,
there is no need to be tested just to find out if you have HPV now.
However, you should get tested for signs of disease that HPV can
cause, such as cervical cancer.
Is there a treatment for HPV or related diseases?
There is no treatment for the virus itself, but a healthy immune system can usually fight off HPV naturally.
There are treatments for the diseases that HPV can cause:
CDC-INFO Contact Center
Prevention Information Network (NPIN)
American Cancer Society. Cancer Facts & Figures, 2008. Atlanta:
American Cancer Society: 2008.
Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813-9.
FUTURE II Study Group. Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection J Infect Dis. 2007; 196:1438-1446.
FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007; 356(19):1915-27.
Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, et al. Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007; 356(19):1928-43.
Koutsky LA, Kiviat NB. Genital human papillomavirus. In: K. Holmes, P. Sparling, P. Mardh et al (eds). Sexually Transmitted Diseases, 3rd edition. New York: McGraw-Hill, 1999, p. 347-359.
Kiviat NB, Koutsky LA, Paavonen J. Cervical neoplasia and other STD-related genital tract neoplasias. In: K. Holmes, P. Sparling, P. Mardh et al (eds). Sexually Transmitted Diseases, 3rd edition. New York: McGraw-Hill, 1999, p. 811-831.
Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2007; 56: 1-24.
Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. American Journal of Epidemiology 2000; 151(12):1158-1171.
Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007;370(9596):1414.
Weinstock H, Berman S, Cates W. Sexually transmitted disease among American youth: Incidence and prevalence estimates, 2000. Perspectives on Sexual and Reproductive Health 2004; 36: 6-10.
Winer R, Hughes JP, Feng Q, et al. Consistent condom use from time of first vaginal intercourse and the risk of genital human papillomavirus infection in young women. N Engl J Med. 2006;354:2645-2654.